Comparison of 3-drug versus 4-drug and PI versus non-PI combinations as initial HAART: Experience from 1998 to 2007

Journal of the International Association of Physicians in AIDS Care

Volumn 8, Issue 5, 2009, Pages 299-307

  Jhaveri, Malhar A ^a   Browning, Steven R ^a   Bush, Heather ^a   Thornton, Alice ^b   Greenberg, Richard N ^b,c  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

HIV; nucleoside reverse transcriptase inhibitors; protease inhibitors; treatment naive

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ADENINE; ATAZANAVIR; BENZOXAZINE DERIVATIVE; DEOXYCYTIDINE; DRUG DERIVATIVE; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE; LAMIVUDINE, ZIDOVUDINE DRUG COMBINATION; NEVIRAPINE; OLIGOPEPTIDE; ORGANOPHOSPHORUS COMPOUND; OXAZINE DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; PROTEINASE INHIBITOR; PYRIDINE DERIVATIVE; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; COHORT ANALYSIS; DRUG COMBINATION; DRUG HYPERSENSITIVITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; UNITED STATES; VIRUS LOAD;

ADENINE; ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BENZOXAZINES; COHORT STUDIES; DEOXYCYTIDINE; DRUG COMBINATIONS; DRUG HYPERSENSITIVITY; FEMALE; HIV INFECTIONS; HUMANS; KENTUCKY; LAMIVUDINE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEVIRAPINE; OLIGOPEPTIDES; ORGANOPHOSPHORUS COMPOUNDS; OXAZINES; PHOSPHONIC ACIDS; PROTEASE INHIBITORS; PYRIDINES; RETROSPECTIVE STUDIES; SEX FACTORS; VIRAL LOAD; YOUNG ADULT; ZIDOVUDINE;

EID: 75349091279     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109709345666     Document Type: Article

References (12)

1. Hammer SM, Squires KE, Hughes MD, et al., for the AIDS Clinical Trials Group 320 Study Team. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997 ; 337 (11). 725-733. (Pubitemid 27417971)
2. Palella FJ Jr, Delaney KM, Moorman AC, et al., and the HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998 ; 338 (13). 853-860.
3. Hirsch MS, Günthard HF, Schapiro JM, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2008 ; 47 (2). 266-285. (Pubitemid 351920631)
4. Gulick RM, Ribaudo HJ, Shikuma CM, et al. Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial. JAMA. 2006 ; 296 (7). 769-781. (Pubitemid 44223101)
5. Chesney MA Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000 ; 30 (suppl 2). S171 - S176.
6. Ngo C., Sansgiry SS Comment: factors affecting patient adherence to highly active antiretroviral therapy. Ann Pharmacother. 2004 ; 38 (3). 511 ; author reply 511. (Pubitemid 38235351)
7. Escobar I., Campo M., Martín J., Fernández-Shaw C., Pulido F., Rubio R. Factors affecting patient adherence to highly active antiretroviral therapy. Ann Pharmacother. 2003 ; 37 (6). 775-781. (Pubitemid 36618359)
8. Ramírez García P., Côté JK Factors affecting adherence to antiretroviral therapy in people living with HIV/AIDS. J Assoc Nurses AIDS Care. 2003 ; 14 (4). 37-45.
9. Lafeuillade A. Factors affecting adherence and convenience in antiretroviral therapy. Int J STD AIDS. 2001 ; 12 (suppl 4). 18-24. (Pubitemid 33035824)
10. Moore AL, Kirk O., Johnson AM, et al., for the EuroSIDA Group. Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited. J Acquir Immune Defic Syndr. 2003 ; 32 (4). 452-461. (Pubitemid 36363161)
11. Gordillo V., del Amo J., Soriano V., González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999 ; 13 (13). 1763-1769. (Pubitemid 30015725)
12. Riddler SA, Haubrich R., DiRienzo AG, et al., for the AIDS Clinical Trials Group Study A5142 Team. Class-sparing regimens for initial treatment of HIV-1 infection. N Engl J Med. 2008 ; 358 (20). 2095-2106. (Pubitemid 351679596)